UCSF Benioff Children's Hospitals are harnessing next-generation genomic technology to develop individualized drug cocktails in a new trial for children with a type of malignant brain tumor. This precision-medicine approach ...
Aug 30, 2018
0
8
Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center have discovered how different mutations in a specific gene help drive glioblastoma, the most lethal form of brain cancer.
Jul 11, 2018
0
3
Glioma is the most common type of primary malignant brain tumor in the United States; glioblastoma being the most common type of glioma in adults. While sex differences in the incidence and survival rates of glioma were known, ...
Jun 28, 2018
0
17
Scientists have a new tactic with potential for fighting medulloblastoma, the most common and most aggressive form of brain tumor in children.
Jun 11, 2018
0
0
It takes an "A" team to make headway against glioblastoma, a highly aggressive type of brain cancer. Glioblastoma is the most common type of malignant brain tumor in adults. In addition to the caliber of the researchers involved, ...
Jun 6, 2018
0
7
Research by Barrow Neurological Institute physicians and University of Washington scientists on novel imaging technology for malignant brain tumors was published in the April issue of World Neurosurgery. The research was ...
May 9, 2018
0
1
A delicate balance during brain development could have profound implications for understanding and treating medulloblastoma, the most common malignant brain tumor affecting children.
Mar 29, 2018
0
24
Zika virus, known for causing microcephaly in babies by attacking the cells that give rise to the fetus's cerebral cortex, could be an alternative for treatment of glioblastoma, the most common and aggressive malignant brain ...
Feb 22, 2018
0
58
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) is one of four cancer centers involved in testing a new "nanomedicine" ...
Jan 9, 2018
0
299
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer ...
Nov 27, 2017
0
2
